Re-Treatment With 177Lu-DOTATATE in Patients With Neuroendocrine Tumors: Multicenter Real-World Experience

被引：0
|
作者：
Navalkissoor, S. [1 ]
Essler, M. [2 ]
Caplin, M. [1 ]
Van Der Zwan, W. [3 ]
Wicharz, M. [2 ]
De Herder, W. [3 ]
Broberg, P. [4 ]
Krenning, E. [3 ]
机构：
[1] Royal Free London NHS Fdn Trust, London, England
[2] Univ Klinikum Bonn, Bonn, Germany
[3] Erasmus MC, Rotterdam, Netherlands
[4] Adv Accelerator Applicat, Geneva, Switzerland
来源：
PANCREAS | 2021年 / 50卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
C-27
引用
收藏
页码：453 / 453
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF RE-TREATMENT WITH 177LU-DOTATATE VERSUS NO RE-TREATMENT WITH 177LU-DOTATATE IN PATIENTS WITH PROGRESSIVE MIDGUT NEUROENDOCRINE TUMORS
    Leeuwenkamp, O.
    Mahon, R.
    Singh, M. K.
    Khare, A.
    [J]. VALUE IN HEALTH, 2020, 23 : S446 - S446
  • [2] 177Lu-DOTATATE Treatment In Unresectable Neuroendocrine Tumors: Our Experience
    Agudelo, M.
    Bello-Arques, P.
    Olivan-Sasot, P.
    Prado-Wohlwend, S.
    Sanchez-Vano, R.
    Yepes-Agudelo, A.
    Martinez-Sanchis, B.
    Bernal-Vergara, J.
    Figueroa-Ardila, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S596 - S597
  • [3] 177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors
    Das, Satya
    Al-Toubah, Taymeyah
    El-Haddad, Ghassan
    Strosberg, Jonathan
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (11) : 1023 - 1031
  • [4] 177Lu-DOTATATE in neuroendocrine tumors: Real-world evidence of efficacy and safety in a community setting
    Sassic, Jessica
    Farasat, Sadaf
    Hermel, David
    Sigal, Darren
    Xavier, Marin Feldman
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] 177Lu-DOTATATE/DOTATOC Re-Treatment in Patients With Progressive Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
    Strosberg, J.
    Leeuwenkamp, O.
    Siddiqui, M. K.
    [J]. PANCREAS, 2021, 50 (03) : 452 - 452
  • [6] 177Lu-Dotatate for Midgut Neuroendocrine Tumors
    Matuchansky, Claude
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (14): : 1391 - 1391
  • [7] Efficacy and Safety of 177Lu-DOTATATE in Lung Neuroendocrine Tumors: A multicenter study
    Mitjavila Casanovas, M.
    Pubul, V.
    Bello, P.
    Miguel, B.
    Cano, J.
    Balaguer, D.
    Garcia-Burillo, A.
    Marino Mendez, A.
    Rodeno, E.
    Custodio, A.
    Pineiro, A.
    Garcia-Canamaque, L.
    Castellon, M.
    Orduna, M.
    Carmona-Bayonas, A.
    Jimenez-Fonseca, P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S103 - S104
  • [8] Efficacy of Everolimus Combined with 177Lu-Dotatate in the Treatment of Neuroendocrine Tumors
    Aljubran, Ali
    Badran, Ahmed
    Alrowaily, Mohamed
    Raef, Hussein
    Alzahrani, Ahmed M.
    Almuhaideb, Ahmed
    Almanea, Hadeel
    El-Dali, Abdelmoneim
    Tuli, Mahmoud
    Bazarbashi, Shouki
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2024, 39 (02) : 164 - 168
  • [9] Effectiveness and Safety of Retreatment with 177Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States
    Delpassand, Ebrahim S.
    Yazdi, Soheil M.
    Ghantoji, Shashank
    Nakasato, Antonio
    Strickland, Corinne
    Nunez, Rodolfo
    Shafie, Afshin
    Cork, Susan
    Byrne, Clare
    Tang, Jackson
    Patel, Jeetvan
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (05) : 746 - 752
  • [10] Rapid Progression After 177Lu-DOTATATE in Patients With Neuroendocrine Tumors
    Assi, Hussein A.
    Hornbacker, Kathleen
    Shaheen, Shagufta
    Wittenberg, Theresa
    Silberman, Robyn
    Kunz, Pamela L.
    [J]. PANCREAS, 2021, 50 (06) : 890 - 894
12345